By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Illumina has scheduled its annual shareholders meeting for April 18, during which the fate of Roche's $5.7 billion hostile bid for Illumina could be determined.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.
Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.
Researchers have found a new kind of virus — one that starts out broken up into five parts.
Nature News explores the president's "science legacy."